Furthermore, using survival analysis, it was discovered that the lower expression of HHIP was linked to shorter recurrence‐free survival (RFS) and progression‐free survival (PFS) of HCC patients (Figure 5L). The gene discussed is HHIP; the disease is hepatocellular carcinoma.